FDA Inspection 992265 — Gauke Healthcare Co., Ltd.
The FDA completed an inspection of Gauke Healthcare Co., Ltd. on November 15, 2016 in Huanggang. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- November 15, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Huanggang (China)